These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23360158)

  • 21. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.
    Yu P; Xiong S; He Q; Chu Y; Lu C; Ramlogan CA; Steel JC
    Immunology; 2009 Aug; 127(4):500-11. PubMed ID: 19604303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
    Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R
    Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y; Streilein JW; Ksander BR
    Transplantation; 1999 Oct; 68(7):963-70. PubMed ID: 10532535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunisation as a strategy for enhancing corneal allograft survival.
    Ma D; Mellon J; Niederkorn JY
    Br J Ophthalmol; 1997 Sep; 81(9):778-84. PubMed ID: 9422933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival.
    Niederkorn JY
    Eye (Lond); 1995; 9 ( Pt 2)():215-8. PubMed ID: 7556720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunology and immunomodulation of corneal transplantation.
    Niederkorn JY
    Int Rev Immunol; 2002; 21(2-3):173-96. PubMed ID: 12424842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J
    Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
    Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
    Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New thoughts on the immunology of corneal transplantation.
    Streilein JW
    Eye (Lond); 2003 Nov; 17(8):943-8. PubMed ID: 14631401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats.
    Hildebrand A; Jarsch C; Kern Y; Böhringer D; Reinhard T; Schwartzkopff J
    Mol Vis; 2014; 20():1749-57. PubMed ID: 25558177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts.
    Streilein JW; Yamada J; Dana MR; Ksander BR
    Transplant Proc; 1999 May; 31(3):1472-5. PubMed ID: 10330973
    [No Abstract]   [Full Text] [Related]  

  • 38. Corneal Allografts: Factors for and against Acceptance.
    Sakowska J; Glasner P; Zieliński M; Trzonkowski P; Glasner L
    J Immunol Res; 2021; 2021():5372090. PubMed ID: 34642632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-risk corneal allografts and why they lose their immune privilege.
    Niederkorn JY
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):493-7. PubMed ID: 20689406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.
    Ksander BR; Sano Y; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):49-52. PubMed ID: 8762010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.